GTO ID | GTD0322 |
Accession | E-MTAB-11315 |
Gene therapy-related clinical trial | GTC2404 |
Altered gene | S |
Gene xrefs |
Gene ID:
1489668
|
Treatment | ARCT-021(ARCT COVID-19 vaccine) |
Control | Click to openARCT.101.1102.Day1_05;ARCT.101.1107.Day1_10;ARCT.101.2103.Day1_07;ARCT.101.2106.Day1_04;ARCT.101.2108.Day1_01;ARCT.101.2111.Day1_01;ARCT.101.3101.Day1_01;ARCT.101.3104.Day1_10;ARCT.101.4103.Day1_09;ARCT.101.4107.Day1_01;ARCT.101.4117.Day1_11;ARCT.101.4119.Day1_05;ARCT.101.5104.Day1_04;ARCT.101.5108.Day1_08;ARCT.101.5109.Day1_09;ARCT.101.5116.Day1_04;ARCT.101.6103.Day1_09;ARCT.101.6108.Day1_05;ARCT.101.6110.Day1_01;ARCT.101.6111.Day1_05;ARCT.101.7103.Day1_03;ARCT.101.7105.Day1_09;ARCT.101.7108.Day1_01;ARCT.101.7115.Day1_05;ARCT.101.8105.Day1_03;ARCT.101.8106.Day1_07;ARCT.101.8109.Day1_07;ARCT.101.8112.Day1_07 |
Case | Click to openARCT.101.2101.Day1_01;ARCT.101.2102.Day1_04;ARCT.101.2104.Day1_10;ARCT.101.2105.Day1_01;ARCT.101.2107.Day1_07;ARCT.101.2109.Day1_05;ARCT.101.2110.Day1_09;ARCT.101.2112.Day1_05;ARCT.101.2113.Day1_09;ARCT.101.2114.Day1_09;ARCT.101.5101.Day1_01;ARCT.101.5102.Day1_02;ARCT.101.5103.Day1_03;ARCT.101.5105.Day1_05;ARCT.101.5106.Day1_06;ARCT.101.5107.Day1_07;ARCT.101.5110.Day1_10;ARCT.101.5111.Day1_11;ARCT.101.5112.Day1_12;ARCT.101.5113.Day1_01;ARCT.101.5114.Day1_02;ARCT.101.5115.Day1_03;ARCT.101.7101.Day1_09;ARCT.101.7102.Day1_12;ARCT.101.7104.Day1_06;ARCT.101.7106.Day1_12;ARCT.101.7107.Day1_09;ARCT.101.7109.Day1_05;ARCT.101.7110.Day1_09;ARCT.101.7111.Day1_01;ARCT.101.7112.Day1_05;ARCT.101.7113.Day1_09;ARCT.101.7114.Day1_10;ARCT.101.7116.Day1_09 |
Disease | COVID-19 |
Disease information |
Disease group: Infection Definition: A Coronavirus infection that is characterized by fever, cough and shortness of breath and that has_material_basis_in SARS-CoV-2. Xref: DO:0080600 |
Organism | Homo sapiens |
Tissue/Cell type | blood |
Characteristics | Day1;5 microgram |
Strategy | Microarray |
Platform | A-MTAB-668 |
ID | Terms | Size | ES | NES | P-value | Adjusted P-value | Plot |
---|